Related Experiment Video
Updated: May 27, 2026

11:05
Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
Published on: February 21, 2019
Enhanced selectivity for sulfatide by engineered human glycolipid transfer protein
Valeria R Samygina1, Alexander N Popov, Aintzane Cabo-Bilbao
1Structural Biology Unit, CIC bioGUNE, Technology Park of Bizkaia, 48160 Derio-Bilbao, Spain.
Structure (London, England : 1993)
|November 15, 2011
Summary
Human glycolipid transfer protein (GLTP) engineering enhances specificity for glycosphingolipids (GSLs). This structural insight offers potential new therapies for GSL-related diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Medicine
Background:
- Human glycolipid transfer protein (GLTP) possesses a unique fold for lipid binding and transfer.
- Glycosphingolipids (GSLs) are crucial regulators of cellular processes including growth, division, adhesion, and neurodevelopment.
Purpose of the Study:
- To perform structure-guided engineering of GLTP to modify its lipid-binding properties.
- To investigate the molecular mechanisms underlying GLTP's selective lipid binding and translocation.
Main Methods:
- X-ray crystallography was used to determine the structures of wild-type GLTP, GLTP mutants, and GLTP-lipid complexes.
- Site-directed mutagenesis was employed to alter specific residues at the GLTP portal entrance.
- Analysis of crystal structures revealed conformational changes associated with lipid binding and encapsulation.
Main Results:
- Crystal structures of GLTP mutants (D48V and A47D‖D48V) bound to N-nervonoyl-sulfatide elucidated the basis for selective sulfatide anchoring.
- Mutations at residues A47 and D48 were shown to regulate sphingosine access to the hydrophobic pocket, potentially via homodimerization.
- Conformational changes involving phenylalanines within the hydrophobic pocket were observed during lipid encapsulation, as seen in apo-GLTP and GLTP-N-oleoyl-glucosylceramide complexes.
Conclusions:
- Engineered GLTP variants exhibit enhanced specificity for particular GSLs.
- Understanding GLTP's structure-function relationship provides a foundation for developing novel therapeutics targeting GSL-mediated diseases.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
